TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
RF Business Division	9.98B	12.77B	11.81B	12.40B	26.43B
RF Business Division Growth	-21.83%	8.12%	-4.76%	-53.09%	8.20%
Pharmaceutical/Bio Business Division	34.72B	26.87B	25.89B	16.49B	15.23B
Pharmaceutical/Bio Business Division Growth	29.22%	3.78%	57.05%	8.24%	16.99%
Elimination of Internal Transactions, Etc.	-1.54B	-1.78B	-1.40B	-1.06B	-3.82B
Total	43.16B	37.87B	36.31B	27.83B	37.84B
Total Growth	13.99%	4.29%	30.46%	-26.46%	14.18%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea	36.05B	31.68B	30.21B	18.64B	20.00B
South Korea Growth	13.80%	4.85%	62.07%	-6.78%	4.39%
Asia	3.54B	2.56B	2.86B	6.00B	14.88B
Asia Growth	38.32%	-10.70%	-52.27%	-59.68%	34.21%
North America	3.58B	3.63B	3.23B	3.19B	2.97B
North America Growth	-1.47%	12.37%	1.32%	7.54%	2.27%
Total	43.16B	37.87B	36.31B	27.83B	37.84B
Total Growth	13.99%	4.29%	30.46%	-26.46%	14.18%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 30, 2026

Data Sources Report a data error